In Vivo Biosafety Testing

Charles River has laboratories in both the United States and Europe accredited against the relevant regulatory standards to perform in vivo biosafety testing. This testing is necessary for viral vaccines and cell lines used to produce biologicals to ensure they are free of adventitious viral agents.

Safety testing for extraneous toxins is required for lot release of biological products intended for human use and requirements also exist for the tumorigenic properties of some cell substrates to be determined. Charles River has the capabilities to conduct these tests. Studies are customizable to fulfill specific client needs.

In Vivo Biosafety Testing Services

  • Mouse/Rat/Hamster Antibody Production (MAP/RAP/HAP) Test - simultaneously detects and identifies viral contaminants in biological specimens
  • Inapparent Virus Assay - screens cell lines for extraneous viruses that do not cause any cytopathic or other cytological effects in cell culture; protocols designed to meet various regulatory requirements
  • Safety Test/Abnormal Toxicity - determines the safety of a biomedical product in support of investigational and new drug filings; required by federal policy for biologics and vaccine development
  • Tumorigenicity Test - determines the tumorigenic potential of a cell line

You may also be interested in...

Release Testing

Release testing services for bulk drug substances and clinical and marketed products for the European Union (EU), United States (US) and other regulatory-distinct markets.

Regulatory Document Library

We have compiled an online library of regulatory documents from the FDA, EMA, MHLW, WHO and more to assist you as you move through your development and release process.

Keeping Vaccines Safe From Harm

This Eureka blog answers the question, ‘Are in vitro tests sufficient screening tools for viral safety and product purity?’

Upcoming Webinar: Next Generation Sequencing

Have questions about Next Generation Sequencing and how it can be incorporated into a viral safety program? So did we. Register for this webinar to get answers from our partner, PathoQuest.